OVERVIEW
Hopec Pharma is pioneering the redefinition of Non-Muscle Invasive Bladder Cancer (NMIBC) treatment.
Driven by a team of seasoned healthcare professionals with strong business experience in the healthcare ecosystem, our company is dedicated to pioneering innovative cancer therapies.
Our flagship product, UPEC-FimON, represents a significant advancement in bladder cancer treatment, offering a more effective and patient-friendly alternative to existing therapies. Our work is grounded in scientific excellence, strategic collaborations, and a commitment to improving patient outcomes.
VISION STATEMENT
We aim to be a global leader in innovative cancer therapies, offering hope and extending lives through advanced research and technology.
MISSION STATEMENT
We strive to revolutionize Bladder Cancer treatment through innovative therapies, extending lives and restoring hope to patients worldwide.

LEADERSHIP TEAM
Hopec Pharma is guided by a team of visionary leaders with deep expertise in healthcare, pharmaceuticals, and business development. Our leadership team brings together decades of experience in drug development, strategic planning, and innovation, all united by a shared commitment to transforming the treatment landscape for Non-Muscle Invasive Bladder Cancer (NMIBC).

SCIENTIFIC TEAM
Hopec Pharma’s Science Team comprises leading experts in bacterio-oncology, immunology, and urologic oncology. These distinguished researchers and clinicians, who are the inventors of UPEC-FimOn, provide the scientific foundation for our groundbreaking therapies and guide our mission to revolutionize bladder cancer treatment.
ADVISORY BOARD
Hopec Pharma’s Advisory Board is composed of seasoned professionals with extensive experience in biotechnology, pharmaceuticals, oncology, and strategic business development. Their diverse insights and guidance are crucial to shaping Hopec Pharma’s strategic direction and ensuring the successful advancement of our innovative therapies.
CORE VALUES
At Hopec Pharma, our core values drive our mission to transform cancer treatment.
These principles shape our culture and define our relationships with patients, partners, and each other.

Integrity
We maintain the highest ethical standards, building trust in our science and business practices.

Communication
We foster open, direct, and respectful dialogue, empowering the exchange of ideas and solutions.

Professionalism
We pursue excellence with dedication, consistently striving for breakthroughs in therapy.

Innovation
We tackle challenges with determination, pushing the boundaries of cancer treatment.

Compassion
We act with kindness and responsibility toward patients, colleagues, and the broader community.

Patient Focus
Improving patient outcomes is at the core of every decision and action we take.